uniQure N.V.

XTRA:UQ1 Stock Report

Market Cap: €899.2m

uniQure Past Earnings Performance

Past criteria checks 0/6

uniQure has been growing earnings at an average annual rate of 32.3%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been growing at an average rate of 64.8% per year.

Key information

32.3%

Earnings growth rate

35.7%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate64.8%
Return on equity-29.8%
Net Margin-204.1%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How uniQure makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XTRA:UQ1 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2261-1255151
30 Jun 2262-114490
31 Mar 22525324550
31 Dec 21524330560
30 Sep 21500321540
30 Jun 21500303520
31 Mar 2138-139460
31 Dec 2038-125430
30 Sep 206-166400
30 Jun 205-136380
31 Mar 206-124350
31 Dec 197-124340
30 Sep 196-105320
30 Jun 198-103290
31 Mar 199-92270
31 Dec 1811-83250
30 Sep 1812-90260
30 Jun 1811-78250
31 Mar 1813-78250
31 Dec 1713-79250
30 Sep 1720-67240
30 Jun 1725-72230
31 Mar 1724-71260
31 Dec 1625-73250
30 Sep 1620-76280
30 Jun 1616-90290
31 Mar 1614-90260
31 Dec 1511-82230

Quality Earnings: UQ1 is currently unprofitable.

Growing Profit Margin: UQ1 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: UQ1 is unprofitable, but has reduced losses over the past 5 years at a rate of 32.3% per year.

Accelerating Growth: Unable to compare UQ1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: UQ1 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-26.8%).

Return on Equity

High ROE: UQ1 has a negative Return on Equity (-29.77%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/07 08:45
End of Day Share Price 2022/08/10 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

uniQure N.V. is covered by 31 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
James BirchenoughBMO Capital Markets Equity Research
Madhu KumarB. Riley Securities, Inc.